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 ABSTRACT                                                                                                                                            
A population frequency analysis of the FABP2 gene 
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Background: Intestinal fatty acid-binding protein (IFAPB) is expressed only 
in intestinal enterocytes. It may participate in the uptake, intracellular metabo-
lism and/or transport of long chain fatty acids. A polymorphism at codon 54 in 
exon 2 of the FABP2 gene, which encodes for the IFAPB, exchanges an alanine 
(Ala) for threonine (Thr). The goal of this study was to determine the frequency 
of the Ala54Thr FABP2 polymorphism in the Egyptian population.
Patients and Methods: Genotyping was carried out in 180 unrelated Egyp-
tian subjects. DNA was extracted from blood samples for genotype analysis. 
A PCR-RFLP assay was applied for the determination of Ala54Thr FABP2 
polymorphism. Allele frequencies were calculated by direct counting. Hardy 
Weinberg Equilibrium was evaluated using a Chi-square goodness of fit test.
Results: Showed that 102 (56.7%) of the studied Egyptian subjects were ho-
mozygous for the Ala54/Ala54 genotype, 60 (33.3%) were heterozygous for 
the Ala54/Thr54 genotype and 18 (10.0%) were homozygous for the Thr54/
Thr54 genotype. The frequencies of the allele Ala54 and the allele Thr54 of the 
FABP2 Gene were found to be 0.733 and 0.267, respectively. The results re-
vealed a similar population polymorphism frequency as in previous European 
studies.
Conclusion: This is the first study to look at the population frequency of the 
Thr54 allele in Egypt.




FABP2 gene polymorphism, Egyptians, 
human population genetics.
BACKGROUND                                          
Fatty acid – binding proteins (FABPs) 
are intracellular proteins found in many 
tissues. They are involved in fatty acid 
transfer and metabolism1. The FABPs 
are a family of 15-kDa proteins which 
are abundantly found in cytosol, rep-
resenting up to 6% of protein depend-
ing on cell type2,3. Approximately 10 
separate mammalian FABP have been 
identified4. FABP2 are encoded by a 
family of different genes. The FABP2 
gene encodes intestinal FABP (I-FABP), 
which is expressed only in intestinal en-
terocytes5. The FABP2 gene consists of 
approximately 3.4 kilobases located in 
chromosomal region 4q28-4q316. It me-
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diates the absorption and transport of 
fatty acids inside the enterocyte and has 
a high affinity for both saturated and un-
saturated long chain fatty acids7. The G 
to A polymorphism at codon 54 in exon 
2 of the human FABP2 gene exchanges 
an Alanine (Ala) in the small helical re-
gion of the protein for Threonine (Thr). 
Thr-containing protein has been shown 
to have 2-fold greater affinity for long-
chain fatty acids than does Ala-contain-
ing protein8. This greater affinity has 
been suggested to cause increased ab-
sorption and processing of fatty acids8. 
The Ala54Thr polymorphism is the 
most extensively studied FABP2 vari-
ant, as this variant seems the most like-
ly candidate to alter the protein’s func-
tion. Different studies suggest that the 
Ala-to-Thr substitution is in fact a func-
tional mutation8,9. If the FABP2 gene 
polymorphism in any way modifies 
the absorption of fatty acids, it could 
in turn affect the lipid metabolism and/
or correlate with cardiovascular disease 
risk. Earlier studies have shown that the 
IFABP Thr54 allele is significantly as-
sociated with higher total cholesterol, 
with stroke incidence10, elevation of 
fasting and postprandial triglyceride11, 
higher nonesterified fatty acid concen-
trations12 and insulin resistance in the 
Pima Indians8, Native Canadians13 and 
Mexican-Americans14. Also, the Thr al-
lele has been associated with visceral 
fat in Japanese subjects15, triglycerides 
in Finnish hyperlipidemic males16 and 
Body Mass Index and percent body fat 
in Aboriginal Canadians13. There are 
many contradicting studies, however, 
that have found non-significant associa-
tion with these parameters17-20. 
The frequencies of the FABP2 al-
leles have been studied in many ethnic 
groups and demonstrated interethnic 
variation in their distribution. The fre-
quency of the wild-type alanine allele 
was highest in Tongans (Polynesians)21 
and lowest in the Japanese22. However, 
no information is available for Egyptian 
population. In the light of the potential 
physiological role of the FABP2 poly-
morphism, the goal of this study was to 
determine the frequency of the Thr54 
allele in the Egyptian population.
PATIENTS AND METHODS                     
Subjects:
The blood samples studied were col-
lected from 180 unrelated individuals 
from the city of Ismailia, Egypt. A writ-
ten informed consent from all partici-
pants included in this study was done 
under institutionally approved internal 
review board protocols. This study was 
carried out in the Arabian Gulf Univer-
sity, Bahrain.
Genotype analysis:
DNA extracted from blood samples by 
standard methods23. The DNA samples 
were analyzed using polymerase chain 
reaction-restriction fragment length 
polymorphism (PCR-RFLP) method24. 
A 180-bp fragment was amplified. DNA 
was amplified in a total volume of 25 μl, 
with the upstream primer: 5’-ACAG-
GTGTTAATATAGTGAAAAG-3’ and 
the downstream primer: 5’-TACCCT-
GAGTTCAGTTCCGTC-3’9. The PCR 
program consisted of an initial denatur-
ation step at 94οC for 5 min followed by 
32 cycles of denaturation at 94οC for 30 
s, annealing at 55οC for 30s and exten-
sion at 72οC for 30s. The final extension 
step was performed at 72οC for 10 min. 
For Restriction Fragment length Poly-
morphism (RFLP) analysis, 5 μl of PCR 
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product were incubated with 0.4 μl of 
enzyme HhaI (GCG/C) (10 U/μl, New 
England Biolabs) in a final volume of 
10 μl overnight at 37°C. The products 
were run on 3% agarose gel containing 
1mg/mL ethidium bromide, electropho-
resed for 40 min at 120 volts and pho-
tographed under ultraviolet light. The 
PCR products that lack the HhaI site 
migrate as one 180-bp fragment (those 
carrying the Thr-54), but PCR products 
containing the HhaI site are cleaved to 
two fragments (a 99-bp and an 81-bp).
Statistical analysis:
Genotype and Allele frequencies were 
calculated by direct counting. Hardy 
Weinberg Equilibrium was evaluated 
using a Chi square goodness of fit test. 
The confidence limits were calculated 
by the online statistic tool.25
RESULTS                                                         
The genotype and allele frequencies of 
Ala54/ Thr54 mutation in the Egyptian 
population have been shown in Table 1. 
The study population was found to be in 
Hardy–Weinberg equilibrium. The data 
in Table 1 show that the Ala54/Ala54 
genotype is the most prevalent (56.67%) 
followed by Ala54/Thr54 (33.33%) and 
Thr54/Thr54 (10.00%). In this Egyp-
tian population sample, the frequencies 
of allele Ala54 and allele Thr54 were 
0.733 (95% CI, 0.684-0.778) and 0.267 
(95% CI, 0.222-0.316), respectively. 
Figure 1 shows the electrophoresis pat-
terns for FABP2 genotypes by PCR-
RFLP based assay.
Table 1: Distribution of the various FABP2 genotype and allele frequencies among the Egyp-
tian population.
Egyptians








Ala 54 Thr 54 Observed Expected
Ala54/Ala54 56.7 (53.9)
0.733 0.267 0.333 0.392Ala54/Thr54 33.3 (38.9)
Thr54/Thr54 10 (7.2)
Fig. 1: Electrophoresis patterns for FABP2 genotypes by PCR-RFLP based assay, persons with 
homozygous genotype (Ala54/Ala54) (lanes 1, 3-7 and 10), homozygous genotype (Thr54/Thr54) (lane 
9) or heterozygous genotype (Ala54/Thr54) (lanes 2, 8 and 11), are shown. M is 100 bp DNA marker.
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The observed genotype results did 
not differ significantly from the ex-
pected genotypes for a population in 
Hardy Weinberg equilibrium (Table 1) 
(p > 0.05, Chi squared goodness of fit). 
Comparison of reported population fre-
quencies for the FABP2 genotypes and 
alleles are given in (Table 2).









Ala/Ala Ala/Thr Thr/Thr Ala Thr
Egyptians (180) 56.7 33.3 10 0.733 0.267 This study
Finnish (170) 49 45 5 0.725 0.275 0.7290 (19)
Sweden (59) 52.5 35.6 11.9 0.703 0.297 0.1492 (10)
United Kingdom (69) 62.3 31.9 5.8 0.783 0.217 0.0105 (26)
Middle Europe (102) 51.0 43.1 5.9 0.726 0.275 0.7401 (26)
South Europe (90) 56.7 36.7 6.7 0.750 0.250 0.4131 (26)
Japanese (258) 45 41 14 0.665 0.345 0.0003 (22)
Indians (899) 53.6 39.3 7.1 0.732 0.268 1 (27) 
Argentineans (202) 52.0 40.6 7.4 0.723 0.277 0.6547 (24)
Native Canadians (188) 0.74 0.24 0.02 0.860 0.140 0.0001 (13)
African Americans (1831) 60 35 5 0.775 0.225 0.0333 (28)
Tongans (1022) 76 23 1 0.876 0.124 0.0001 (21)
DISCUSSION                                                  
The present study investigated for the 
first time the frequency of the Ala54Thr 
SNP in FABP2 gene among 180 unre-
lated Egyptians and compared the re-
sults with data reported for other ethnic 
groups (Table 2).
The observed frequency of the Thr54 
allele (0.267) in Egyptian subjects is 
similar to that reported in different Eu-
ropean countries including, North Eu-
rope: Finland19 and Sweden10; Middle 
Europe26: Denmark, Germany, Belgium 
and Switzerland; southern Europe26: 
Portugal, Italy, Spain and Greece. Also, 
it is similar to that reported in Argentin-
eans, who are mostly of Europeans de-
scent24. It is significantly different from 
that of British.26
The frequency of the wild Ala54 allele
among Egyptians is significantly differ-
ent from that reported for the Japanese22. 
It is also different from the African-
Americans27, Native Canadians13 and 
Tongans (Polynesians)21. Interestingly, 
the frequency of the wild Ala54 allele in 
Egyptians subjects did not differ from 
that reported in Indians28. There were
no available data from literature in oth-
er Arab population for comparison.
It is well known that the single nucle-
otide polymorphism (SNP) at codon 54 
of the FABP2 gene is a missence vari-
ant that has a definite effect on the pri-
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mary structure of the protein and affects 
its fatty acid binding properties. It is not 
known, however, whether this change 
can affect the lipid metabolism of carri-
ers29. Many earlier studies have reported 
associations between this polymorphism 
and insulin resistance, BMI, dyslipi-
demia, stroke, metabolic syndromes and 
hypertriglyceridemia5,8, 10-13,27,30. The Thr 
polymorphism has been associated with 
diabetes related variables in Mexican 
Americans14, Pima Indians8,31, Japanese 
men22, Indian migrants32 and various 
Caucasian populations33-35. In contrast, 
other studies report no association with 
the same parameters16,35-37. Part of the 
discrepancy among the studies may 
come from the different dietary habits 
of the analyzed populations.38
Thr-containing protein has been shown 
to have 2-fold greater affinity for long-
chain fatty acids than does Ala-con-
taining protein8. This greater affinity 
has been suggested to cause increased 
absorption and processing of fatty ac-
ids8. In the present study, about 10% of 
Egyptian subjects were homozygous for 
the Thr54 allele and 27% of them have 
at least one Thr allele, with their Thr-
containing proteins may have greater 
affinity to long-chain fatty acids which 
may leads to increased absorption and 
processing of fatty acids in those sub-
jects. This group of population may be 
liable to different types of diseases as-
sociated with increase absorption of the 
long-chain fatty acid including, cardio-
vascular diseases, stroke, obesity, dia-
betes, etc. Association studies between 
Thr54 allele of FABP2 gene and these 
diseases among Egyptians are needed.
CONCLUSION                                                 
It should be noted that this was the first 
description of Thr54 allele of FABP2 
gene in Egyptian population which 
does not exclude the possibility of the 
presence of new SNPs unique to the 
Egyptian population. The population 
frequency of the Thr54 allele in Egypt 
does not differ from previously reported 
frequencies in European populations.
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